THORATEC (NASDAQ:THOR)
29.06
0.26 (0.89%)
| THORATEC (NASDAQ:THOR) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $29.32 | 52 Week High | $33.43 | ||
| Open | $29.21 | 52 Week Low | $18.56 | ||
| Day High | $29.45 | P/E | 66.05 | ||
| Day Low | $28.86 | EPS | $0.44 | ||
| Volume | 720,963 | ||||
| More THOR Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| HTWR | 5 | KNDL | 4 |
| EGLE | 3 | RDN | 3 |
| ACTU | 3 | ALL | 3 |
| CSCO | 3 | CECO | 3 |
| ONNN | 3 | GIVN | 3 |
| AGU | 3 | BEE | 3 |
Entities who have mentioned THOR
- Banc of America | View Related Stories »
- After-Hours Movers | View Related Stories »
- Crude Oil | View Related Stories »
- Dividend | View Related Stories »
- UBS | View Related Stories »
- Canaccord Adams | View Related Stories »
- Treasury Capital Purchase Program | View Related Stories »
- Standard & Poor's | View Related Stories »
- Trading Radar | View Related Stories »
- Barclays | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Natixis Bleichroeder | View Related Stories »
- Stock Buyback | View Related Stories »
- Notable Mergers and Acquisitions | View Related Stories »
- Lazard | View Related Stories »
- Morgan Stanley | View Related Stories »
- Piper Jaffray | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Needham & Co | View Related Stories »
- Citi | View Related Stories »
- Factory Orders | View Related Stories »
- Robert W Baird | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- Layoffs | View Related Stories »
- Vanguard | View Related Stories »
View All Major News StreetInsider.com Major News for THOR
- Thoratec (THOR) Tops Q3 EPS by 3c; Guides
- Thoratec Corporation (THOR) Tops Q1 View By 6c; Re-affirms
- Thoratec (THOR) To Acquire HeartWare In $282M Deal
View All ReportsStreetInsider.com Reports on THOR
- Auriga Reiterates a 'Buy' Rating on Thoratec Corp. (THOR); Strong Pivotal Data Should Lead to DT Approval
- Thoratec Lab (THOR) volatility decreases as shares rally 10% on positive trial data
- Thoratec (THOR) Releases Data for HeartMate II Pivotal Trial
- Barrington Research Initiates Coverage on Thoratec (THOR) with an Outperform
- Natixis Bleichroeder Upgrades Thoratec (THOR) to Buy
View All Press ReleasesCompany Press Releases on THOR
- Destination Therapy Trial Data Demonstrate Superiority for HeartMate II(R) Over HeartMate(R) XVE
- Thoratec Investor Meeting to Review HeartMate II (R) Destination Therapy Trial Data to Be Webcast
- Thoratec Presentation at Canaccord Adams Conference to be Webcast
- Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
- Thoratec Schedules Third Quarter Conference Call, Webcast
StreetInsider Reports on THOR by Category
View All BlogsBlogs on THOR
- Bulls Charge Thoratec Pre-Earnings
- Best Performing Mid and Small Cap Stocks Since 10/9/07 Peak
- Analyst upgrades, downgrades and initiations: AMAT, CSCO, GD, HOT, LIZ, RBS ...
- First Coverage: Market Sentiment Still Bullish
- Weekly Street Sentiment: A Rally in Motion Stays in Motion
View All FilingsSEC Filings on THOR
- Form 4 THORATEC CORP For: Nov 13 Filed by: DIMICK NEIL F
- Form 8-K THORATEC CORP For: Nov 04
- Form 4 COLE J DANIEL For: Oct 06
Comments on recent THOR articles
Comments on THOR
No comments are currently available.
on Mar 16, 2009
at 12:01 PM AtriCure- heart Can the radio frequency make a heart bleed during a double by pass surgery
Article: Canaccord Adams Downgrades AtriCure (ATRC) to Hold